60 full members, 18 associate members, and 1 provisional member The european union’s new framework for health technology assessment (hta) regulation (eu 2021/2282) represents a unique opportunity to strengthen the involvement of patient communities in hta processes Strong and informed input from patients and patient representation is necessary to support this new framework and efficient hta. At the same time, the european medicines agency and the large federations of rare disease patient organizations (pos), such as eurordis, contributed to a great cultural change, by promoting a. Grants and donations collaboration between industry, health professionals and healthcare organisations benefits patients It is a relationship that has delivered numerous innovative medicines and changed the way many diseases impact on our lives
Industry and health professionals collaborate in a range of activities from clinical research to sharing best clinical practice and exchanging. Scope this efpia patient organisation code covers relationships between efpia corporate members including their subsidiaries and contracted third parties (e.g Agencies) and patient organisations which operate in europe Improve cvd patients’ lives the efpia cardiovascular health platform represents ten efpia member companies committed to r&d in cardiovascular disease, an area with still high unmet need, with the aim to highlight the importance of early detection, the right diagnosis, and secondary prevention for improving cvd patients’ lives in europe The platform strives to achieve this by.
OPEN
